No Detail Found!

Apolipoprotein as an indicator of coronary artery disease risk in normolipidemic subjects after myocardial infarction

Author(s)
Khem A Kariraand Department of Biochemistry, Basic Medical Sciences Institute, Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Mohammad Saleh Soomro Department of Physiology, Chandka Medical College, Larkana.Pakistan
Abstract
The study investigated whether apolipoprotein (apo) A-I and B could better identify patients than lipid lipoproteins in a male population with recent acute myocardial infarction which could differentiate normolipidemic subjects with an increased risk of myocardial infarction. Serum lipids, HDL-C, LDL-C and apo A-I and B were determined in 34 hyperlipidemic and 31 normolipidemic survivors of myocardial infarction and compared with matched control. A significant decreased level of HDL-C and apo A-I (P<0.01,P<0.05) and an increased level of LDL-C and apo B (P<0.001,P<0.05) was found in all the patients. The data supports the view that apo A-I and B as well as its ratio (X2 values 11.11,18.84 and 28.51 respectively, P<0.001) were better indicators of lipid derangement in normolipidemic survivors of myocardial infarction than the levels of LDL-C and HDL-C. Our findings also suggests that determination of apo A-I and B and its ratio are better predictors of coronary artery disease even in patients with normal plasma lipid level.
Publication Details
Page(s) 281-283
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 10, Issue: 8, Year: 2000

Request the full text from PASTIC

Keywords
Apolipoprotein A-I Apolipoprotein B Lipoproteins, HDL cholesterol Lipoproteins, LDL cholesterol Myocardial infarction Coronary heart disease Atherosclerosis
References
Abbot RD .1991 .Incidence of coronary heart disease and lipoprotein cholesterol levels: Framingham study. JMai Vase, 256 : 2835-8.
Zambon A,Hokanson JE,Brown BG .1999 .BrunzelJlD. Evidence for a new pathophysiological mechanism for coronary artey disease regression. Hepatic lipasemediated changes in LDL density. Circulation, 99 : 1959-64.
Gordon DJ .1989 .High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation, 79 : 8-15.
Mocarelli P .1998 .Plasma apolipoproteins A-1 and B in survivors of myocardial infarction and in a control group. Ciin Chem, 44 : 134-40.
Ford ES,Simmons B .1990 .CastaneAr. Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease. J din Epidemiol, 43 : 425-32.
Bon GB .1979 .Are apolipoproteins better discriminators than lipids for atherosclerosis?. Lancet, 1 : 901-03.
.1994 .Evaluation of apolipoproteins A-1 and B in survivors of myocardial infarction. JAssoc Physicians India, 42 : 703-05.
. .Plasma levels of apolipoprotein A-1 and apolipoprotein B in human atherosclerosis. Artery1978;, 4 : 385-94.
. .Serum lipoproteins and apolipoproteins in young normocholesterolaemic non-diabetic Indian men with myocardial infarction. PostgradMedJ1991, 67 : 159-94.
. .Plasma lipoproteins: apolipoprotein structure and function. JLipidRes 198A;, 25 : 1277-94.
.1980 .Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors. Atherosclerosis, 36 : 67-74.
.1992 .Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men. Am J Cardio, 69 : 1251-4.
De BackerG . .Discriminative value of lipids and apoproteins in coronary heart disease. , 2 : 197-203.
. .Relationship between HDL-cholesterol and apolipoprotein A-1 and the severity of coronary artery disease. EurHeartJ\S&>\, 16 : 465-70.
. .Indicators of lipoprotein metabolism in normolipemic men after myocardial infarction. Gas Lek, 134 : 577-9.
Ross JW .1995 .National Cholesterol Education Program recommendations for measurement of low density lipoprotein cholesterol: executive summary. Ciin Chem, 41 : 1414-20.
Wood PD .1995 .National Cholesterol Education Program recommendations for measurement of high density lipoprotein cholesterol: executive summary. din Chem, 41 : 1427-33.
.1996 .Measurement of apoproteins: time to improve the diagnosis and treatment of the atherogenic dyslipoproteinemias. Ciin Chem, 42 : 489-91.
G .1978 .Plasma levels of apolipoprotein A-1 and apolipoprotein B in human atherosclerosis. Artery, 4 : 385-9.
Samad A .1996 .Incidence of acute myocardial infarction. PakdCard, 7 : 13-17.
0

Citations

0

Downloads

106

Views